CG
Christopher Gasink
Gastroenterology
Credentials: · ·
History
Research
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
New England Journal of Medicine · 2016 · 1,543 citations
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Nature Immunology · 2005 · 1,050 citations
Ustekinumab induction and maintenance therapy in refractory Crohn's disease
New England Journal of Medicine · 2012 · 924 citations
16 papers · 9 as a resident
11 papers
9 papers
8 papers
- DJ
7 papers
- ST
6 papers
- WD
5 papers
4 papers
